{"AllianceGenome": "3587", "HGNC": "3587", "MIM": "613897", "_id": "2188", "_version": 1, "accession": {"genomic": ["AC103801.2", "AY928335.1", "CH471064.2", "CP068267.2", "NC_000011.10", "NC_060935.1", "NG_007425.1"], "protein": ["AAF26297.1", "AAF26298.1", "AAH47028.1", "AAH63038.1", "AAH93867.1", "AAI01808.1", "AAX09677.1", "BAB14433.1", "BAD96997.1", "BAG50967.1", "CAE45999.1", "EAW68319.1", "NP_073562.1", "Q9NPI8.1"], "rna": ["AF181994.1", "AF181995.1", "AK001716.2", "AK023153.1", "AK223277.1", "BC035346.1", "BC047028.1", "BC063038.1", "BC093867.1", "BC101807.1", "BI522448.1", "BX640996.1", "CB157038.1", "NM_022725.4"], "translation": [{"protein": "AAF26298.1", "rna": "AF181995.1"}, {"protein": "CAE45999.1", "rna": "BX640996.1"}, {"protein": "BAB14433.1", "rna": "AK023153.1"}, {"protein": "AAF26297.1", "rna": "AF181994.1"}, {"protein": "NP_073562.1", "rna": "NM_022725.4"}, {"protein": "BAG50967.1", "rna": "AK001716.2"}, {"protein": "BAD96997.1", "rna": "AK223277.1"}, {"protein": "AAH93867.1", "rna": "BC093867.1"}, {"protein": "AAH47028.1", "rna": "BC047028.1"}, {"protein": "AAI01808.1", "rna": "BC101807.1"}, {"protein": "AAH63038.1", "rna": "BC063038.1"}]}, "alias": "FAF", "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": {"classification": "definitive", "classification_date": "2021-02-03T22:54:56.822Z", "disease_label": "Fanconi anemia complementation group F", "gcep": "Hereditary Cancer Gene Curation Expert Panel", "moi": "AR", "mondo": "MONDO:0011325", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_60719ed8-36fa-4d11-93b2-8036133510a6-2021-02-03T225456.822Z", "sop": "SOP8"}}, "ensembl": {"gene": "ENSG00000183161", "protein": "ENSP00000330875", "transcript": "ENST00000327470", "translation": [{"protein": "ENSP00000330875", "rna": "ENST00000327470"}], "type_of_gene": "protein_coding"}, "entrezgene": "2188", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 5.21937485, "exp_mis": 185.344073, "exp_syn": 75.19382, "lof_z": 0.528710213945848, "mis_z": 0.515347820880557, "mu_lof": 4.23670803944e-07, "mu_mis": 1.6321413088e-05, "mu_syn": 6.59958949029e-06, "n_lof": 4.0, "n_mis": 171.0, "n_syn": 72.0, "p_li": 0.00381453403362032, "p_null": 0.357794607019573, "p_rec": 0.638390858946806, "syn_z": 0.228333064203647}, "bp": 1125, "cds_end": 22647356, "cds_start": 22646231, "n_exons": 1, "nonpsych": {"exp_lof": 4.7034024, "exp_mis": 167.733641, "exp_syn": 68.0370252, "lof_z": 0.318529549215778, "mis_z": 0.534854921643194, "mu_lof": 4.23670803944e-07, "mu_mis": 1.6321413088e-05, "mu_syn": 6.59958949029e-06, "n_lof": 4.0, "n_mis": 154.0, "n_syn": 62.0, "p_li": 0.00322855371118923, "p_null": 0.424593548338081, "p_rec": 0.572177897950729, "syn_z": 0.460801777426476}, "nontcga": {"exp_lof": 4.79981373, "exp_mis": 170.5145486, "exp_syn": 69.17630363, "lof_z": 0.810394751831533, "mis_z": 0.591927147230709, "mu_lof": 4.23670803944e-07, "mu_mis": 1.6321413088e-05, "mu_syn": 6.59958949029e-06, "n_lof": 3.0, "n_mis": 155.0, "n_syn": 66.0, "p_li": 0.020751792029048, "p_null": 0.229428214511608, "p_rec": 0.749819993459344, "syn_z": 0.241804897682409}, "transcript": "ENST00000327470.3"}, "exons": [{"cdsend": 22625810, "cdsstart": 22624685, "chr": "11", "position": [[22622532, 22625823]], "strand": -1, "transcript": "NM_022725", "txend": 22625823, "txstart": 22622532}], "exons_hg19": [{"cdsend": 22647356, "cdsstart": 22646231, "chr": "11", "position": [[22644078, 22647369]], "strand": -1, "transcript": "NM_022725", "txend": 22647369, "txstart": 22644078}], "generif": [{"pubmed": 14647419, "text": "inactivation of the FANC-BRCA pathway is relatively common in solid tumors and may be related to tobacco and alcohol exposure and survival"}, {"pubmed": 15126331, "text": "Inactivation of genes in the FA-BRCA pathway by epigenetic alterations have been found in a high proportion of cervix cancer patients, suggesting a major role for this pathway in the development of cervical cancer."}, {"pubmed": 15262960, "text": "FANCF acts as a flexible adaptor protein that plays a key role in the proper assembly of the FA core complex."}, {"pubmed": 16418574, "text": "results showed that FANCF methylation regulates the expression of FANCF at both mRNA and protein levels; methylation-induced inactivation of FANCF plays an important role in the occurrence of ovarian cancers via disrupting the FA-BRCA pathway"}, {"pubmed": 17082180, "text": "human FANCF protein has specific structural components that function in the assembly of a DNA damage signaling complex"}, {"pubmed": 17932744, "text": "FANCF methylation was rare in breast tumors"}, {"pubmed": 18414472, "text": "This study does not support methylation-dependent silencing of FANCF as a mechanism of sensitisation to platinum-based chemotherapy in ovarian cancer."}, {"pubmed": 18950845, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19064572, "text": "Observational study and meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19536649, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19690177, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19801548, "text": "Data identify the gene encoding Fanconi F (FANCF) as an ICSBP target gene."}, {"pubmed": 19813073, "text": "FANCF methylation is a rare event in Japanese primary invasive breast cancer."}, {"pubmed": 20496165, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 23440494, "text": "Silencing of FANCF enhanced the antiproliferative effect of ADM in OVCAR3 cells."}, {"pubmed": 24996439, "text": "Data suggest that the Fanconi anemia group F protein/BRCA1/2 proteins pathway may be a new target to reverse adriamycin (ADR) resistance in leukemia treatment."}, {"pubmed": 26033879, "text": "careful examination of three electively aborted fetuses in one family and one affected girl in the other indicated an association of the FANCF loss-of-function mutation with a severe phenotype characterized by multiple malformations"}, {"pubmed": 26385482, "text": "Using small interfering RNA (siRNA), knockdown of FANCF, FANCL, or FANCD2 inhibited function of the FA/BRCA pathway in A549, A549/DDP and SK-MES-1 cells, and potentiated sensitivity of the three cells to cisplatin."}, {"pubmed": 26507869, "text": "CpG island methylation of FANCF gene promoter region is strongly associated with the susceptibility and clinicopathologic features of epithelial ovarian cancer."}, {"pubmed": 27714961, "text": "we report three patients who illustrate the clinical variability within the FA-F group. This analysis suggests a more severe phenotype for those with the common c.484_485delCT mutation."}, {"pubmed": 28440438, "text": "LOH in FA genes appears to be a common feature of head and neck squamous cell carcinomas development seen here in 57% of patients and other mutation types may increase this mutation frequency. We suggest larger patient cohorts would be needed to test the observed association of LOH in FANCF and patient survival comprehensively"}, {"pubmed": 31288759, "text": "A mutation in the FANCF gene in Iranian patients with Fanconi anemia. This new mutation correlates with a hematological problem (pancytopenia), short stature, and microcephaly and skin hyperpigmentation. Until now, no evidence of malignancy was detected."}, {"pubmed": 32915143, "text": "FANCF hypomethylation is associated with colorectal cancer in Han Chinese."}], "genomic_pos": {"chr": "11", "end": 22625823, "ensemblgene": "ENSG00000183161", "start": 22622533, "strand": -1}, "genomic_pos_hg19": {"chr": "11", "end": 22647387, "start": 22644079, "strand": -1}, "go": {"BP": [{"evidence": "IBA", "gocategory": "BP", "id": "GO:0006974", "qualifier": "involved_in", "term": "DNA damage response"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0036297", "pubmed": 19965384, "qualifier": "involved_in", "term": "interstrand cross-link repair"}], "CC": [{"evidence": "IDA", "gocategory": "CC", "id": "GO:0000785", "pubmed": 22343915, "qualifier": "part_of", "term": "chromatin"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0043240", "qualifier": "part_of", "term": "Fanconi anaemia nuclear complex"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0043240", "pubmed": 20347428, "qualifier": "part_of", "term": "Fanconi anaemia nuclear complex"}, {"evidence": "NAS", "gocategory": "CC", "id": "GO:0043240", "pubmed": 22343915, "qualifier": "part_of", "term": "Fanconi anaemia nuclear complex"}], "MF": [{"category": "MF", "evidence": "ND", "id": "GO:0003674", "qualifier": "enables", "term": "molecular_function"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [11063725, 12649160, 32296183, 32814053], "qualifier": "enables", "term": "protein binding"}]}, "homologene": {"genes": [[7955, 692250], [8364, 100145108], [9031, 101750641], [9544, 704048], [9598, 749534], [9606, 2188], [9913, 539681], [10090, 100040608], [10116, 499155]], "id": 75185}, "interpro": [{"desc": "Fanconi anemia group F protein", "id": "IPR035428", "short_desc": "FANCF"}, {"desc": "FANCF, C-terminal domain superfamily", "id": "IPR038505", "short_desc": "FANCF_C_sf"}], "ipi": "IPI00009290", "map_location": "11p14.3", "name": "FA complementation group F", "other_names": ["Fanconi anemia complementation group F", "Fanconi anemia group F protein"], "pantherdb": {"HGNC": "3587", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "3689889", "ortholog_type": "LDO", "panther_family": "PTHR14449", "taxid": 10090, "uniprot_kb": "E9Q5Z5"}, {"RGD": "1561456", "ortholog_type": "LDO", "panther_family": "PTHR14449", "taxid": 10116, "uniprot_kb": "F1M0R6"}, {"Ensembl": "ENSGALG00000003660", "ortholog_type": "LDO", "panther_family": "PTHR14449", "taxid": 9031, "uniprot_kb": "E1C4T8"}, {"ZFIN": "ZDB-GENE-060306-3", "ortholog_type": "LDO", "panther_family": "PTHR14449", "taxid": 7955, "uniprot_kb": "F1QDH6"}, {"EnsemblGenome": "AT5G44010", "ortholog_type": "LDO", "panther_family": "PTHR14449", "taxid": 3702, "uniprot_kb": "A0A1P8B9K4"}], "uniprot_kb": "Q9NPI8"}, "pathway": {"biocarta": [{"id": "atrbrcapathway", "name": "role of brca1 brca2 and atr in cancer susceptibility"}, {"id": "bard1pathway", "name": "brca1 dependent ub ligase activity"}], "kegg": {"id": "hsa03460", "name": "Fanconi anemia pathway - Homo sapiens (human)"}, "pid": [{"id": "bard1pathway", "name": "BARD1 signaling events"}, {"id": "fanconi_pathway", "name": "Fanconi anemia pathway"}], "reactome": [{"id": "R-HSA-1169410", "name": "Antiviral mechanism by IFN-stimulated genes"}, {"id": "R-HSA-1280215", "name": "Cytokine Signaling in Immune system"}, {"id": "R-HSA-168256", "name": "Immune System"}, {"id": "R-HSA-6783310", "name": "Fanconi Anemia Pathway"}, {"id": "R-HSA-73894", "name": "DNA Repair"}, {"id": "R-HSA-913531", "name": "Interferon Signaling"}, {"id": "R-HSA-9833482", "name": "PKR-mediated signaling"}], "wikipathways": {"id": "WP4946", "name": "DNA Repair Pathways Full Network"}}, "pdb": ["2IQC", "7KZP", "7KZQ", "7KZR", "7KZS", "7KZT", "7KZV"], "pfam": "PF11107", "pharmgkb": "PA28001", "pharos": {"target_id": 19907, "tdl": "Tchem"}, "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF249247", "relationship": "is"}, {"id": "GNF249248", "relationship": "similar to"}, {"id": "GNF249249", "relationship": "is"}, {"id": "GNF249250", "relationship": "is"}], "GNF_mm+hs-MGC": [{"id": "GNF131281", "relationship": "is"}, {"id": "GNF278870", "relationship": "is"}], "NOVART_hs-genome_siRNA": {"id": "GNF148752", "relationship": "is"}}, "refseq": {"genomic": ["NC_000011.10", "NC_060935.1", "NG_007425.1"], "protein": "NP_073562.1", "rna": "NM_022725.4", "translation": {"protein": "NP_073562.1", "rna": "NM_022725.4"}}, "reporter": {"HG-U133_Plus_2": ["218689_at", "222713_s_at"], "HG-U95B": "56843_at", "HTA-2_0": "TC11001498.hg.1", "HuEx-1_0": ["2719481", "3366519"], "HuGene-1_1": "7947138", "HuGene-2_1": "16736722"}, "summary": "The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group F. [provided by RefSeq, Jul 2008].", "symbol": "FANCF", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1414532"}, "unigene": "Hs.632151", "uniprot": {"Swiss-Prot": "Q9NPI8", "TrEMBL": "A3KME0"}, "wikipedia": {"url_stub": "FANCF"}}